Navigation Links
Acromegaly in Medical News

Options Improving for Patients With Acromegaly and Gigantism

Scientific, technological and medical advances made in the past two decades are leading to more definitive diagnoses, earlier and more effective treatment options/// and better outcomes for patients suffering from a condition called acromegaly. In the article, Shlomo Melmed, M.D., senior vice ...

Indevus Pharmaceuticals Announces First Quarter Fiscal 2009 Financial Results

...by Endo in the future upon achievement of certain milestones related to NEBIDO(R) (in development for hypogonadism) and octreotide (in development for acromegaly and carcinoid syndrome), two of the Company's primary product candidates. The acquisition will be effected by means of a tender offer for all the outs...

Indevus Pharmaceuticals Announces Definitive Merger Agreement With Endo Pharmaceuticals

...sm) and the octreotide implant (in development for acromegaly and carcinoid syndrome), two of Indevus' primary p...he FDA for marketing and sale for the treatment of acromegaly or carcinoid syndrome. The tender offer is ex...-transmitted pathogens, the octreotide implant for acromegaly and carcinoid syndrome, and pagoclone for stutteri...

Endo Pharmaceuticals to Acquire Indevus Pharmaceuticals

...ncer, NEBIDO(R) for hypogonadism, PRO 2000 for the prevention of infection by HIV and other sexually-transmitted pathogens, the octreotide implant for acromegaly and carcinoid syndrome, and pagoclone for stuttering. About Endo Pharmaceuticals Endo Pharmaceuticals is a specialty pharmaceutical compan...

Look younger with HGH!!

... Mr Prakash said: "Taken in low doses, research shows that human growth hormone is as safe as vitamin C”. Long-term usage can also result in acromegaly — a condition that causes oily skin, a large tongue and protruding forehead. Dr Cooper said: “Sufferers sometimes have a huge chin, huge spade-l...
Acromegaly in Medical Technology

FDA Accepts Complete Response Submission to New Drug Application for NEBIDO(R)

...ncer, NEBIDO(R) for hypogonadism, PRO 2000 for the prevention of infection by HIV and other sexually-transmitted pathogens, the octreotide implant for acromegaly and carcinoid syndrome, and pagoclone for stuttering. Safe Harbor Statement This press release contains forward-looking statements w...

Indevus Pharmaceuticals Announces PRO 2000 Found to Show Promise in Large HIV Prevention Study

...ncer, NEBIDO(R) for hypogonadism, PRO 2000 for the prevention of infection by HIV and other sexually-transmitted pathogens, the octreotide implant for acromegaly and carcinoid syndrome, and pagoclone for stuttering. PRO 2000 PRO 2000 (a naphthalene sulfonate polymer) is under development as a topica...

Indevus Announces Agreement With Teva to Develop Pagoclone for the Treatment of Stuttering

...IDO(R) for male hypogonadism, PRO 2000 for the prevention of infection by HIV and other sexually-transmitted pathogens, and the octreotide implant for acromegaly and carcinoid syndrome. About Pagoclone Pagoclone is a novel, non-benzodiazepine, selective GABA-A receptor agonist. In clinical studies in anxiet...

ATL/TV1102 Trial Results Presented at World Congress on Treatment and Research in Multiple Sclerosis

...L1103 is a second-generation antisense drug designed to lower blood IGF-I levels and is entering pre-clinical development as a potential treatment for acromegaly and vision disorders. ATL/TV1102 (inhaled) is at the pre-clinical research stage as a potential treatment for asthma. ATL1101 is a second-generation a...

Indevus Pharmaceuticals Reports Positive Results of Phase II Octreotide Implant Trial

...same patented Hydron technology utilized in the Company's currently approved and marketed products SUPPRELIN(R) LA and VANTAS(R). About Acromegaly acromegaly is a chronic hormonal disorder that occurs when a pituitary tumor produces excess growth hormone, or GH. It most commonly affect middle- aged adults, ...

Ambrilia Highlights Encouraging Data for its HIV Integrase Inhibitor Program and Recent Developments at Annual Meeting

...ious partnering and product development strategies to move forward with PCK3145. - The pivotal Phase III clinical trial in Europe with Octreotide in acromegaly patients was initiated in February and Ambrilia obtained an IND with its U.S. licensing partner, Mallinckrodt, to conduct a pivotal Phase III clinical...
Acromegaly in Medical Products

Free IGF-I IRMA Test

Description:...mediating many of the actions of GH [6]. In GH deficiency, malnutrition [4] and GH-receptor deficiency [7], serum IGF-I levels are low. Conversely, in acromegaly (GH excess) serum IGF-I levels are elevated [4,6]. Measurement of IGF-I levels in serum is a useful diagnostic test for the clinical evaluation of GH-...
Company:Diagnostic Systems Laboratories, Inc.

IGF-I IRMA Test (With Extraction)

Description:...mediating many of the actions of GH [6]. In GH deficiency, malnutrition [4] and GH-receptor deficiency [7], serum IGF-I levels are low. Conversely, in acromegaly (GH excess) serum IGF-I levels are elevated [4,6]. Measurement of IGF-I levels in serum is a useful diagnostic test for the clinical evaluation of GH-...
Company:Diagnostic Systems Laboratories, Inc.

IGF-I ELISA Test (With Extraction)

Description:...mediating many of the actions of GH [6]. In GH deficiency, malnutrition [4] and GH-receptor deficiency [7], serum IGF-I levels are low. Conversely, in acromegaly (GH excess) serum IGF-I levels are elevated [4,6]. Measurement of IGF-I levels in serum is a useful diagnostic test for the clinical evaluation of GH-...
Company:Diagnostic Systems Laboratories, Inc.

IGF-I IRMA Test (Non-Extraction)

Description:...mediating many of the actions of GH [6]. In GH deficiency, malnutrition [4] and GH-receptor deficiency [7], serum IGF-I levels are low. Conversely, in acromegaly (GH excess) serum IGF-I levels are elevated [4,6]. Measurement of IGF-I levels in serum is a useful diagnostic test for the clinical evaluation of GH-...
Company:Diagnostic Systems Laboratories, Inc.

IGF-I ELISA Test (Non-Extraction)

Description:...mediating many of the actions of GH [6]. In GH deficiency, malnutrition [4] and GH-receptor deficiency [7], serum IGF-I levels are low. Conversely, in acromegaly (GH excess) serum IGF-I levels are elevated [4,6]. Measurement of IGF-I levels in serum is a useful diagnostic test for the clinical evaluation of GH-...
Company:Diagnostic Systems Laboratories, Inc.

Free IGF-I ELISA Test

Description:...mediating many of the actions of GH [6]. In GH deficiency, malnutrition [4] and GH-receptor deficiency [7], serum IGF-I levels are low. Conversely, in acromegaly (GH excess) serum IGF-I levels are elevated [4,6]. Measurement of IGF-I levels in serum is a useful diagnostic test for the clinical evaluation of GH-...
Company:Diagnostic Systems Laboratories, Inc.
Acromegaly in Medical Definition

Pathology

... Hypoparathyroidism ( Pseudohypoparathyroidism ) - Hyperparathyroidism ( Primary , Secondary , Tertiary ) Pituitary hyperfunction ( acromegaly , Hyperprolactinaemia , Syndrome of inappropriate antidiuretic hormone ) - Hypopituitarism ( Sheehan's syndrome , Kallmann syndrome , Simmonds' ...
Acromegaly in Medical Dictionary

Acromegaly

Acromegaly is a syndrome that results when the pituitary gland produces excess growth hormone (hGH) after epiphyseal plate closure at puberty. A number of disorders may increase the pituitary's GH output, although most... Defines acromegaly , a disorder caused by excess production ...

Giantism

...iantism at Dictionary.com a free online dictionary ... Link To giantism . acromegaly Facts. Get the facts and take charge of your condition. ... Definition ...often used to specifically denote growth hormone excess, the term ... acromegaly is a growth disorder caused by excessive production of growth hormone ......

Gigantism

...m is usually the result of hereditary and ... acromegaly and Gigantism Definition acromegaly is a disease in which an abnormality in the pitu...ess of growth hormone during ... A review of acromegaly & Gigantism with focus on etiology, pathogen...

Breech birth

... ... This means it is not the breech birth that causes the problem, but may be a ... Abandonment, Abdominal Wall Defects, Acetaminophen, Acne, acromegaly and Gigantism, Acting Out, Adaptive Behavior ... Breech birth is the delivery of a ... Delivery of a breech through the birth canal can be...

Brachial plexopathy

... in the arm and ... Brachial plexopathy Health Article. Save Email Print. Images ... Abandonment, Abdominal Wall Defects, Acetaminophen, Acne, acromegaly and Gigantism, Acting Out, Adaptive Behavior Scales ... Brachial plexopathy occurs most ... Brachial plexopathy - Overview, Brachial pl...

Agammaglobulinemia

...s/Candler, Savannah Georgia ... Agammaglobulinemia is rare disorder that primarily ... Abandonment, Abdominal Wall Defects, Acetaminophen, Acne, acromegaly and Gigantism, Acting Out, Adaptive Behavior Scales for Infants and Early Childhood, Addiction, ... ...
Acromegaly in Biological Technology

Indevus Pharmaceuticals Announces Release of 2008 Annual Report

...ncer, NEBIDO(R) for hypogonadism, PRO 2000 for the prevention of infection by HIV and other sexually-transmitted pathogens, the octreotide implant for acromegaly and carcinoid syndrome, and pagoclone for stuttering. Contact: Michael W. Rogers EVP and Chief Financial Officer (781) 861-8444...

Indevus Pharmaceuticals Announces Fiscal 2008 Year End and Fourth Quarter Results

...Trial of PRO 2000 -- Phase III Clinical Trial of Octreotide Implant for acromegaly Initiated Business Development -- Licensing of European Rights fo...by HIV and other sexually-transmitted pathogens, the octreotide implant for acromegaly and carcinoid syndrome, and pagoclone for stuttering. About SANCTUR...

Indevus Pharmaceuticals to Present at Upcoming Investor Conferences

... NEBIDO(R) for male hypogonadism, PRO 2000 for the prevention of infection by HIV and other sexually-transmitted pathogens, the octreotide implant for acromegaly and carcinoid syndrome, and pagoclone for stuttering. Forward Looking Statements Except for the descriptions of historical facts contained herein,...

Indevus and FDA Agree on Path Forward for NEBIDO(R)

...IDO(R) for male hypogonadism, PRO 2000 for the prevention of infection by HIV and other sexually-transmitted pathogens, and the octreotide implant for acromegaly and carcinoid syndrome. Forward Looking Statements Except for the descriptions of historical facts contained herein, this press release contains f...

Gleevec Receives FDA Priority Review as First Therapy to Reduce Recurrence of Gastrointestinal Stromal Tumors After Surgery

...me-positive chronic myelogenous leukemia (Ph+ CML) and five other rare diseases. Novartis also has a therapy for the treatment of carcinoid tumors and acromegaly and multiple treatments in the pipeline targeting rare diseases. Filing data The study on which the regulatory filing is based compared the recurr...

Indevus Announces Private Placement of $105 Million of Non-Recourse Notes

...IDO(R) for male hypogonadism, PRO 2000 for the prevention of infection by HIV and other sexually-transmitted pathogens, and the octreotide implant for acromegaly and carcinoid syndrome. Forward Looking Statements Except for the descriptions of historical facts contained herein, this press release contains f...
Acromegaly in Biological Dictionary

Pituitary gland

...tion, the pituitary gland produces growth hormone for normal development ... PNA Disorders Section - Introduction to the Pituitary Gland . acromegaly ... Structurally, the pituitary gland is divided into a larger anterior region ... pituitary gland n. A small oval endocrine gland attach...
Other Tags
(Date:8/28/2014)... August 29, 2014 Recently, iFitDress.com, the ... new selection of chic bridesmaid dresses . Included ... items. In addition, all of them are provided at ... , iFitDress.com insists on offering fast and reliable delivery ... what they order in a short time. As is ...
(Date:8/28/2014)... August 28, 2014 Blood's Thicker Than Water ... money and family ties in the heart of the city. ... – a story about how disrespect caused two families to ... many streets. , The Yayo Boyz and the M.O.B. Boyz ... speechless and local onlookers in a silent terror. "Guerrilla," AKA ...
(Date:8/28/2014)... FL (PRWEB) August 28, 2014 Millennium ... use affecting users in the workplace. A recent ... Dependence (NCADD) states that drug abuse is costing ... who use or are addicted to drugs affect their ... activities carry over into the workplace, causing expensive problems ...
(Date:8/28/2014)... government plans its exit strategy from the war, now may ... providing health care to veterans, says a Perspective piece in ... simply go on doing more of the same is to ... cost and population structure pose in the longer run," said ... Clinical Practice, and David Auerbach, from the RAND Corporation, in ...
(Date:8/28/2014)... 2014 The Governor of Yucatán, Rolando ... at a press conference; this event is organized by ... of Economy through the National Microenterprise Financing Program ( ... to the 5th at the Convention Center Yucatan Siglo ... a great responsibility for Yucatan to host the 17th ...
Breaking Medicine News(10 mins):Health News:New Selection of Chic Bridesmaid Dresses Available at iFitDress.com 2Health News:Raymond E. Blake Releases Blood's Thicker Than Water, Based on a True Story 2Health News:Drug Use Causes Problems in the Workplace 2Health News:A VA exit strategy 2Health News:Governor of the State of Yucatan presents the 17th Microcredit Summit 2Health News:Governor of the State of Yucatan presents the 17th Microcredit Summit 3
(Date:8/28/2014)... 2014 Dyslexia, the most commonly diagnosed learning ... reading disability that occurs when the regions of ... normally. , The use of non-invasive functional neuroimaging ... disrupted in dyslexia. However, most prior work has ... regions, leaving a gap in our understanding of ...
(Date:8/28/2014)... northern California, and Alaska totaled 515 million board feet ... increase of more than 10 percent compared to the ... Northwest Research Station reported today. During this same period, ... 247 million board feet. , The total value of ... to $390 million in the same quarter, while the ...
(Date:8/27/2014)... Aug. 27, 2014  WaferGen Bio-systems, Inc. (NASDAQ: WGBS) ... underwritten public offering of units of common stock and ... gross proceeds of $20 million, prior to deducting underwriting ... Company.  The shares and warrants are immediately separable and ... sold in the offering consists of 2,000 shares of ...
Breaking Biology News(10 mins):Dyslexic readers have disrupted network connections in the brain 2West coast log exports up, lumber exports down in second quarter of 2014 2WaferGen Bio-Systems Announces Successful Completion of Public Offering Raising $20 Million 2WaferGen Bio-Systems Announces Successful Completion of Public Offering Raising $20 Million 3
Other Contents